The prevalence of psychotic symptoms among methamphetamine users

Addiction

Volumn 101, Issue 10, 2006, Pages 1473-1478

  McKetin, Rebecca ^a   McLaren, Jennifer ^a   Lubman, Dan I ^b   Hides, Leanne ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Comorbidity; Drug use; Methamphetamine; Psychosis; Schizophrenia

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; DIAMORPHINE; METHAMPHETAMINE; PSYCHEDELIC AGENT;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BRIEF PSYCHIATRIC RATING SCALE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG ABUSE; DRUG DEPENDENCE; DRUG USE; FEMALE; HALLUCINATION; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PSYCHOLOGIC TEST; PSYCHOSIS; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; BRIEF PSYCHIATRIC RATING SCALE; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NEW SOUTH WALES; PREVALENCE; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 33748349861     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2006.01496.x     Document Type: Article

References (28)

1. Farrell M., Marsden J., Ali R., Ling W. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 2002; 97: 771-2.
2. United Nations Office on Drugs and Crime. Patterns and trends in amphetamine-type stimulants in East Asia and the Pacific: findings from the 2004 regional ATS questionnaire. Bangkok: United Nations Office on Drugs and Crime, Regional Centre for East Asia and the Pacific, 2005.
3. Parry C., Myers B., Plüddemann A. Drug policy for methamphetamine use urgently needed. S Afr Med J 2004; 94: 964-5.
4. Roehr B. Half a million Americans use methamphetamine every week. BMJ 2005; 331: 476.
5. Asnis R., Smith R. Amphetamine abuse and violence. J Psychedelic Drugs 1978; 10: 317-77.
6. Connell P. H. Amphetamine psychosis. Maudsley monograph no. 5. London: Oxford University Press, 1958.
7. Ellinwood E. H. Assault and homicide associated with amphetamine abuse. Am J Psychiatry 1971; 127: 1170-5.
8. Angrist B. Psychoses induced by central nervous system stimulants and related drugs. In: Creese I., ed. Stimulants: neurochemical, behavioral and clinical perspectives. New York: Raven Press; 1983, p. 1-30.
9. Angrist B., Sathananthan G., Wilk S., Gershon S. Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 1974; 11: 13-23.
10. Davis J. M., Schlemmer R. F. The amphetamine psychosis. In: Caldwell, J., ed. Amphetamine and related stimulants: chemical, biological, clinical and sociological aspects. Florida: CRC Press; 1980, p. 161-73.
11. Harris D., Batki S. L. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 2000; 9: 28-37.
12. Hall W., Hando J., Darke S., Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 1996; 91: 81-7.
13. Chen C. K., Lin S. K., Sham P. C., Ball D., Loh E. W., Hsiao C. C. et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med 2003; 33: 1407-14.
14. Iwanami A., Sugiyama A., Kuroki N., Toda S., Kato N., Nakatani Y. et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. Acta Psychiatr Scand 1994; 89: 428-32.
15. Regier D. A., Farmer M. E., Rae D. S., Locke B. Z., Keith S. J., Judd L. L. et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511-18.
16. Curran C., Byrappa N., McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004; 185: 196-204.
17. Farrell M., Boys A., Bebbington P., Brugha T., Coid J., Jenkins R. et al. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry 2002; 181: 393-8.
18. Dalmau A., Bergman B., Brismar B. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness? Eur Psychiatry 1999; 14: 366-71.
19. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W. et al. The Severity of Dependence Scale (SDS) in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607-14.
20. Topp L., Mattick R. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997; 92: 157-67.
21. Andrews G., Hall W., Teesson M., Henderson S. The mental health of Australians: National Survey of Mental Health and Well-being. Canberra: Commonwealth Department of Health and Ageing; 1999.
22. Degenhardt L., Hall W., Korten A., Morgan V., Jablensky A. Use of a brief screening instrument for psychosis: results of an ROC analysis. NDARC technical report no. 210. Sydney: National Drug and Alcohol Research Centre; 2005.
23. Lukoff D., Nuechterlein K. H., Ventura J. Manual for the expanded Brief Psychiatric Rating Scale. Schizophr Bull 1986; 12: 594-602.
24. STATA Corporation. STATA, version 8 for Windows. Texas: STATA Corporation; 2003.
25. Degenhardt L., Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med 2001; 31: 659-68.
26. Andrews G., Henderson S., Hall W. Prevalence, comorbidity, disability and service utilisation. Br J Psychiatry 2001; 178: 145-53.
27. Hall W. Is cannabis use psychotogenic? Lancet 2006; 367: 193-5.
28. Ventura J., Green M. F., Shaner A., Liberman R. P. Training and quality assurance with the Brief Psychiatric Rating Scale: 'the drift busters'. Int J Meth Psychiatric Research 1993; 3: 221-44.